Award
Delivery Order #SPE2DR26FCZQ4
Delivery Order for XOLAIR Syringe Procurement under Pharmaceutical Services IDV
Buyer
Defense Logistics Agency
Award Amount
$1,579.22
Ceiling
$1,579.22
Awarded
March 04, 2026
Period of Performance
Mar 04, 2026 – Mar 25, 2026
Identifier
SPE2DR26FCZQ4
NAICS
424210
This award represents a delivery order contract, a subset of a larger indefinite delivery vehicle (IDV) contract, focused on pharmaceutical supply logistics. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distribution and services company. They are tasked with the procurement and delivery of a specific pharmaceutical product, XOLAIR 150 MG/ML syringes, a medication usually employed in treating certain chronic conditions. The contract is significant for supporting government healthcare operations by ensuring timely availability of critical medicines. The scope of work includes delivering this medicine from the supplier's location in Park Ridge, Illinois within a short, defined timeframe in March 2026. This delivery order stems from a long-term IDV, awarded through competitive bidding, which covers broader pharmaceutical supply and service provisions to government entities. The limited dollar value reflects a focused, single-delivery procurement within the broader contract framework. The contract furthers the agency's capability to maintain an effective medical supply chain supporting vital public health initiatives.
Description
4571079104!XOLAIR 150 MG/ML SYRINGEML